BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

501 related articles for article (PubMed ID: 30151729)

  • 1. A framework for selection of blood-based biomarkers for geroscience-guided clinical trials: report from the TAME Biomarkers Workgroup.
    Justice JN; Ferrucci L; Newman AB; Aroda VR; Bahnson JL; Divers J; Espeland MA; Marcovina S; Pollak MN; Kritchevsky SB; Barzilai N; Kuchel GA
    Geroscience; 2018 Dec; 40(5-6):419-436. PubMed ID: 30151729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Geroscience-guided repurposing of FDA-approved drugs to target aging: A proposed process and prioritization.
    Kulkarni AS; Aleksic S; Berger DM; Sierra F; Kuchel GA; Barzilai N
    Aging Cell; 2022 Apr; 21(4):e13596. PubMed ID: 35343051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of Clinical Trials to Extend Healthy Lifespan.
    Justice JN; Niedernhofer L; Robbins PD; Aroda VR; Espeland MA; Kritchevsky SB; Kuchel GA; Barzilai N
    Cardiovasc Endocrinol Metab; 2018 Dec; 7(4):80-83. PubMed ID: 30906924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antecedent Metabolic Health and Metformin (ANTHEM) Aging Study: Rationale and Study Design for a Randomized Controlled Trial.
    Kumari S; Bubak MT; Schoenberg HM; Davidyan A; Elliehausen CJ; Kuhn KG; VanWagoner TM; Karaman R; Scofield RH; Miller BF; Konopka AR
    J Gerontol A Biol Sci Med Sci; 2022 Dec; 77(12):2373-2377. PubMed ID: 34865016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Taming expectations of metformin as a treatment to extend healthspan.
    Konopka AR; Miller BF
    Geroscience; 2019 Apr; 41(2):101-108. PubMed ID: 30746605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metformin monotherapy for adults with type 2 diabetes mellitus.
    Gnesin F; Thuesen ACB; Kähler LKA; Madsbad S; Hemmingsen B
    Cochrane Database Syst Rev; 2020 Jun; 6(6):CD012906. PubMed ID: 32501595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Association of Aging Biomarkers, Interstitial Lung Abnormalities, and Mortality.
    Sanders JL; Putman RK; Dupuis J; Xu H; Murabito JM; Araki T; Nishino M; Benjamin EJ; Levy D; Ramachandran VS; Washko GR; Curtis JL; Freeman CM; Bowler RP; Hatabu H; O'Connor GT; Hunninghake GM
    Am J Respir Crit Care Med; 2021 May; 203(9):1149-1157. PubMed ID: 33080140
    [No Abstract]   [Full Text] [Related]  

  • 9. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of metformin on biomarkers associated with breast cancer outcomes: a systematic review, meta-analysis, and dose-response of randomized clinical trials.
    Rahmani J; Manzari N; Thompson J; Gudi SK; Chhabra M; Naik G; Mousavi SM; Varkaneh HK; Clark C; Zhang Y
    Clin Transl Oncol; 2020 Jan; 22(1):37-49. PubMed ID: 31006835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strategies and Challenges in Clinical Trials Targeting Human Aging.
    Newman JC; Milman S; Hashmi SK; Austad SN; Kirkland JL; Halter JB; Barzilai N
    J Gerontol A Biol Sci Med Sci; 2016 Nov; 71(11):1424-1434. PubMed ID: 27535968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A toolkit for quantification of biological age from blood chemistry and organ function test data: BioAge.
    Kwon D; Belsky DW
    Geroscience; 2021 Dec; 43(6):2795-2808. PubMed ID: 34725754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A blast from the past: To tame time with metformin.
    Xenos D; Mecocci P; Boccardi V
    Mech Ageing Dev; 2022 Dec; 208():111743. PubMed ID: 36279989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endpoints for geroscience clinical trials: health outcomes, biomarkers, and biologic age.
    Cummings SR; Kritchevsky SB
    Geroscience; 2022 Dec; 44(6):2925-2931. PubMed ID: 36260264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Clinical Outcomes and Adverse Events Associated With Glucose-Lowering Drugs in Patients With Type 2 Diabetes: A Meta-analysis.
    Palmer SC; Mavridis D; Nicolucci A; Johnson DW; Tonelli M; Craig JC; Maggo J; Gray V; De Berardis G; Ruospo M; Natale P; Saglimbene V; Badve SV; Cho Y; Nadeau-Fredette AC; Burke M; Faruque L; Lloyd A; Ahmad N; Liu Y; Tiv S; Wiebe N; Strippoli GF
    JAMA; 2016 Jul; 316(3):313-24. PubMed ID: 27434443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of Renin-Angiotensin-Aldosterone System blockade in patients admitted to hospital with confirmed coronavirus disease (COVID-19) infection (The McGill RAAS-COVID- 19): A structured summary of a study protocol for a randomized controlled trial.
    Aflaki M; Flannery A; Ferreira JP; Cheng MP; Kronfli N; Marelli A; Zannad F; Brophy J; Afillalo J; Huynh T; Giannetti N; Bessissow A; Ezekowitz JA; Lopes RD; Ambrosy AP; Craig M; Sharma A
    Trials; 2021 Feb; 22(1):115. PubMed ID: 33546734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of metformin on biomarkers and survivals for breast cancer- a systematic review and meta-analysis of randomized clinical trials.
    Zhang ZJ; Yuan J; Bi Y; Wang C; Liu Y
    Pharmacol Res; 2019 Mar; 141():551-555. PubMed ID: 30664988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of initiating insulin and metformin on glycemic control and inflammatory biomarkers among patients with type 2 diabetes: the LANCET randomized trial.
    Pradhan AD; Everett BM; Cook NR; Rifai N; Ridker PM
    JAMA; 2009 Sep; 302(11):1186-94. PubMed ID: 19755697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin secretagogues for prevention or delay of type 2 diabetes mellitus and its associated complications in persons at increased risk for the development of type 2 diabetes mellitus.
    Hemmingsen B; Sonne DP; Metzendorf MI; Richter B
    Cochrane Database Syst Rev; 2016 Oct; 10(10):CD012151. PubMed ID: 27749986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.